William P. Burke

ViewRay®, Inc. (NASDAQ: VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system. They’re changing radiation therapy for the better with accurate, precise, and personalized cancer treatment that no other system delivers, addressing the key limitations of existing external-beam radiation therapy technologies.